Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials-Reference-Cited by-同舟云学术

Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials

Published:2016-11 Issue:11 Volume:25 Page:1102-1111
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

Archer David F.¹,Freeman Ellen W.²,Komm Barry S.³,Ryan Kelly A.³,Yu Ching-Ray⁴,Mirkin Sebastian³,Pinkerton JoAnn V.⁵

Affiliation:

1. Department of Obstetrics and Gynecology, Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia.

2. Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania.

3. Pfizer, Inc., Collegeville, Pennsylvania.

4. Pfizer, Inc., New York, New York.

5. Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, Virginia.

Publisher

Mary Ann Liebert Inc

Subject

General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jwh.2015.5558

Reference37 articles.

1. A prospective population-based study of menopausal symptoms

2. Vulvovaginal Atrophy

3. Management of osteoporosis in postmenopausal women

4. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review

5. Healthcare seeking and treatment for menopausal symptoms in the United States

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of placebo effect in randomized placebo-controlled trials for moderate or severe vasomotor symptoms: a meta-analysis;Menopause;2022-11-01

2. Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis;Gynecological Endocrinology;2022-08-28

3. 2′,3′,4′-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism;Molecular Medicine;2022-04-25

4. Ovarian function and menopause;Pathy's Principles and Practice of Geriatric Medicine;2022-02-18

5. TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial;Menopause;2020-07-13